234 related articles for article (PubMed ID: 37439373)
1. Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment.
D'Alessandro A; Nouraie SM; Zhang Y; Cendali F; Gamboni F; Reisz JA; Zhang X; Bartsch KW; Galbraith MD; Espinosa JM; Gordeuk VR; Gladwin MT
Haematologica; 2023 Dec; 108(12):3418-3432. PubMed ID: 37439373
[TBL] [Abstract][Full Text] [Related]
2. Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients, as a function of therapeutic transfusion and hydroxyurea treatment.
D'Alessandro A; Nouraie SM; Zhang Y; Cendali F; Gamboni F; Reisz JA; Zhang X; Bartsch KW; Galbraith MD; Espinosa JM; Gordeuk VR; Gladwin MT
bioRxiv; 2023 Apr; ():. PubMed ID: 37066337
[TBL] [Abstract][Full Text] [Related]
3.
D'Alessandro A; Nouraie SM; Zhang Y; Cendali F; Gamboni F; Reisz JA; Zhang X; Bartsch KW; Galbraith MD; Gordeuk VR; Gladwin MT
bioRxiv; 2023 Feb; ():. PubMed ID: 36824724
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction.
D'Alessandro A; Nouraie SM; Zhang Y; Cendali F; Gamboni F; Reisz JA; Zhang X; Bartsch KW; Galbraith MD; Gordeuk VR; Gladwin MT
Am J Hematol; 2023 Jul; 98(7):1017-1028. PubMed ID: 36971592
[TBL] [Abstract][Full Text] [Related]
5. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Nevitt SJ; Jones AP; Howard J
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
Rankine-Mullings AE; Nevitt SJ
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
[TBL] [Abstract][Full Text] [Related]
8. Elevated tricuspid regurgitation velocity in congenital hemolytic anemias: Prevalence and laboratory correlates.
Yates AM; Joshi VM; Aygun B; Moen J; Smeltzer MP; Govindaswamy D; Dowdy J; Cotton A; Kang G; Ware RE; Hankins JS
Pediatr Blood Cancer; 2019 Jul; 66(7):e27717. PubMed ID: 30907497
[TBL] [Abstract][Full Text] [Related]
9. Relationship of erythropoietin, fetal hemoglobin, and hydroxyurea treatment to tricuspid regurgitation velocity in children with sickle cell disease.
Gordeuk VR; Campbell A; Rana S; Nouraie M; Niu X; Minniti CP; Sable C; Darbari D; Dham N; Onyekwere O; Ammosova T; Nekhai S; Kato GJ; Gladwin MT; Castro OL
Blood; 2009 Nov; 114(21):4639-44. PubMed ID: 19724057
[TBL] [Abstract][Full Text] [Related]
10. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
[TBL] [Abstract][Full Text] [Related]
11. Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates.
Novelli EM; Kato GJ; Ragni MV; Zhang Y; Hildesheim ME; Nouraie M; Barge S; Meyer MP; Hassett AC; Gordeuk VR; Gladwin MT; Isenberg JS
Am J Hematol; 2012 Mar; 87(3):326-30. PubMed ID: 22318901
[TBL] [Abstract][Full Text] [Related]
12. Degree of anemia, indirect markers of hemolysis, and vascular complications of sickle cell disease in Africa.
Dubert M; Elion J; Tolo A; Diallo DA; Diop S; Diagne I; Sanogo I; Belinga S; Guifo O; Wamba G; Ngo Sack F; Boidy K; Kamara I; Traore Y; Diakite CO; Gbonon V; Faye BF; Seck M; Deme Ly I; Chelo D; N'Guetta R; Diop IB; Gaye B; Jouven X; Ranque B
Blood; 2017 Nov; 130(20):2215-2223. PubMed ID: 28931524
[TBL] [Abstract][Full Text] [Related]
13. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyurea therapy in children severely affected with sickle cell disease.
Scott JP; Hillery CA; Brown ER; Misiewicz V; Labotka RJ
J Pediatr; 1996 Jun; 128(6):820-8. PubMed ID: 8648542
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe.
Nouraie M; Lee JS; Zhang Y; Kanias T; Zhao X; Xiong Z; Oriss TB; Zeng Q; Kato GJ; Gibbs JS; Hildesheim ME; Sachdev V; Barst RJ; Machado RF; Hassell KL; Little JA; Schraufnagel DE; Krishnamurti L; Novelli E; Girgis RE; Morris CR; Rosenzweig EB; Badesch DB; Lanzkron S; Castro OL; Goldsmith JC; Gordeuk VR; Gladwin MT;
Haematologica; 2013 Mar; 98(3):464-72. PubMed ID: 22983573
[TBL] [Abstract][Full Text] [Related]
16. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
[TBL] [Abstract][Full Text] [Related]
17. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD003146. PubMed ID: 28094851
[TBL] [Abstract][Full Text] [Related]
18. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Carpenter A; Dale-Harris I; Dorée C; Estcourt LJ
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012380. PubMed ID: 37539955
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia.
Fitzhugh CD; Hsieh MM; Allen D; Coles WA; Seamon C; Ring M; Zhao X; Minniti CP; Rodgers GP; Schechter AN; Tisdale JF; Taylor JG
PLoS One; 2015; 10(11):e0141706. PubMed ID: 26576059
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
